Selective Metabotropic Glutamate Receptor 5 (mGlu5) Antagonism Reduces L-DOPA-Induced Dyskinesia in MPTP-Lesioned Primates at the Expense of Anti-Parkinsonian Benefit

被引：0
|
作者：
Johnston, Tom H.
Fox, Susan H.
Piggott, Matthew J.
Brotchie, Jonathan M.
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [31] Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys
    Morin, N.
    Morissette, M.
    Gregoire, L.
    Gomez-Mancilla, B.
    Gasparini, F.
    Di Paolo, T.
    MOVEMENT DISORDERS, 2013, 28 : S211 - S211
  • [32] Interactions between antagonists of group 5 metabotropic glutamate receptors (mGluR5) and L-DOPA in rat models of Parkinson's disease and L-DOPA-induced dyskinesia
    Dekundy, A.
    Mela, F.
    van der Elst, M. C. J.
    Pietruszek, M.
    Danysz, W.
    Cenci, M. A.
    MOVEMENT DISORDERS, 2008, 23 (01) : S237 - S237
  • [33] Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
    Kwan, Cynthia
    Frouni, Imane
    Bedard, Dominique
    Hamadjida, Adjia
    Huot, Philippe
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 871
  • [34] Determination of Metabotropic Glutamate 2 Receptor Distribution with [3H]-LY-341,495 in Hemi-Parkinsonian Rats with L-DOPA-Induced Dyskinesia
    Kim, E.
    Shaqfah, J.
    Frouni, I.
    Huot, P.
    MOVEMENT DISORDERS, 2023, 38 : S646 - S646
  • [35] The selective κ-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates
    Cox, Heather
    Togasaki, Daniel M.
    Chen, Li
    Langston, William
    Di Monte, Donato A.
    Quik, Maryka
    EXPERIMENTAL NEUROLOGY, 2007, 205 (01) : 101 - 107
  • [36] The ability of UWA-0101 to enhance anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate may result from mixed, though selective, inhibition of dopamine and serotonin re-uptake
    Johnston, T. H.
    Huot, P.
    Fox, S. H.
    Piggott, M. J.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2009, 24 : S353 - S353
  • [37] Mu-selective, but not non-selective, opioid receptor antagonism reduces L-DOPA induced dyskinesia in the MPTP macaque model of Parkinson's disease
    Fox, S. H.
    Koprich, J. B.
    Johnston, T. H.
    Goodman, A.
    Le Bourdonnec, B.
    Dolle, R. E.
    DeHaven, R. N.
    DeHaven, D. L.
    Little, P. J.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2010, 25 (07) : S412 - S412
  • [38] UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset
    Huot, Philippe
    Johnston, Tom H.
    Lewis, Katie D.
    Koprich, James B.
    Reyes, M. Gabriela
    Fox, Susan H.
    Piggott, Matthew J.
    Brotchie, Jonathan M.
    NEUROPHARMACOLOGY, 2014, 82 : 76 - 87
  • [39] Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L-DOPA-induced dyskinesia
    Dekundy, Andrzej
    Gravius, Andreas
    Hechenberger, Mirko
    Pietraszek, Malgorzata
    Nagel, Jens
    Tober, Carsten
    van der Elst, Martine
    Mela, Flora
    Parsons, Christopher G.
    Danysz, Wojciech
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (12) : 1703 - 1716
  • [40] Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on l-DOPA-induced dyskinesia
    Andrzej Dekundy
    Andreas Gravius
    Mirko Hechenberger
    Małgorzata Pietraszek
    Jens Nagel
    Carsten Tober
    Martine van der Elst
    Flora Mela
    Christopher G. Parsons
    Wojciech Danysz
    Journal of Neural Transmission, 2011, 118 : 1703 - 1716
12345